Search Results

The February decision by the Center for Medicare and Medicaid Innovation (CMMI) to build its first specialty care model around oncology is an important indication of the agency’s focus on how to contain costs in cancer care.

As the U.S. healthcare system undergoes transformative change, cancer programs will require a multifaceted administrative leader to ensure that the program thrives and maintains an acceptable ROI on the significant investments required to deliver quality patient-centered care.

In 2016, we saw the Obama Administration finalize regulations around sweeping physician payment reform in Medicare, oncology practices nationwide navigate the first year of the Oncology Care Model (OCM), policymakers try—and fail—to push through drug pricing reform with a national mandatory demonstration program, the 21st Century Cures Act signed into law, and the drug pricing debate hit a fever …

On Friday, October 14, the Centers for Medicare & Medicaid Services (CMS) released its final rule on the MACRA Quality Payment Program (QPP), solidifying transformational changes in the way physicians will be reimbursed for Medicare Part B services.

Since 1992, Medicare has paid for the services of physicians, non-physician practitioners, and certain other suppliers under the Medicare Physician Fee Schedule (MPFS).